White House Nixes Overton FDA Nomination; Sen. Marshall is Possible Replacement
The White House is withdrawing Heidi Overton's nomination as FDA commissioner due to a lack of congressional support, Axios reported 11/17, just hours before her closely watched Senate committee vote.
The decision follows mounting opposition from Democrats and reservations among Republicans, including Senate Health, Education, Labor and Pensions Committee chairman Bill Cassidy (R-LA), who had questioned Overton's involvement in administration vaccine policies.
As previously reported by FDA Webview, Cassidy remained undecided about supporting Overton ahead of the 11/18 vote.
Semafor has reported that Republicans were discussing Sen. Roger Marshall (R-KS), a physician who lost his reelection bid earlier this month, as a possible replacement. No new nominee has been announced.
A senior administration official told Axios that the White House wants a new direction at FDA consistent with HHS secretary Robert F. Kennedy Jr.'s Make America Healthy Again agenda.
The withdrawal leaves FDA under acting commissioner Kyle Diamantas as the administration searches for a permanent agency chief.